HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative tumor initiating activities of cyclopentano and methyl derivatives of 5-methylchrysene and chrysene.

Abstract
Previous studies showed that 5,6-dimethylchrysene (5,6-diMeC) and 5,7-diMec were significantly less tumorigenic than 5-methylchrysene (5-MeC). These results were unexpected based on the known mechanism of metabolic activation of 5-MeC and indicated the presence of critical steric requirements for tumorigenicity at the 6 and 7 positions of 5-MeC. In this study, the structure activity relationships were further extended by comparing the tumor-initiating activities on mouse skin of 5-MeC, 6,7-cyclopentano-5-MeC, 5,6-diMeC, 6,7-diMeC, 5,7-diMeC, chrysene and 6,7-cyclopentanochrysene. 5-MeC was the most tumorigenic compound, with activity significantly higher than all other compounds tested. Among the other compounds. Only 5,6-diMeC was significantly tumorigenic. The results demonstrate that substitution of methyl or methylene groups at the 6 or 7 positions of 5-MeC leads to a significant reduction of tumor initiating activity.
AuthorsS Amin, S S Hecht, P Di Raddo, R G Harvey
JournalCancer letters (Cancer Lett) Vol. 51 Issue 1 Pg. 17-20 (May 15 1990) ISSN: 0304-3835 [Print] Ireland
PMID2337893 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Carcinogens
  • Chrysenes
  • Phenanthrenes
  • 6,7-cyclopentano-5-methylchrysene
  • 5,6-dimethylchrysene
  • 6,7-cyclopentanochrysene
  • chrysene,2-diol-3,4-epoxide-1
  • 5-methylchrysene
Topics
  • Animals
  • Biotransformation
  • Carcinogens
  • Chemical Phenomena
  • Chemistry
  • Chrysenes (metabolism, toxicity)
  • Female
  • Mice
  • Phenanthrenes (toxicity)
  • Skin Neoplasms (chemically induced)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: